| Ashley Colleen Cleary, ARNP | |
|
208 N 12th St, Bellevue, IA 52031-1931 | |
| (563) 872-4008 | |
| (563) 872-3273 |
| Full Name | Ashley Colleen Cleary |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 208 N 12th St, Bellevue, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851523203 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | A113499 (Iowa) | Primary |
| Entity Name | Medical Associates Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457300790 PECOS PAC ID: 3870491228 Enrollment ID: O20031223000311 |
News Archive
The study, published in the journal Science and Technology of Advanced Materials, by Shinichi Arakawa and colleagues at Tokyo Medical and Dental University and Japan's National Institute of Advanced Industrial Science and Technology, evaluated the bactericidal activities of ozone nano-bubble water - also known as NBW3 - against the two main bacterial agents that cause periodontitis as well as its toxicity to human oral tissue cells.
Press Ganey Associates' 2009 Hospital Pulse Report: Physician Perspectives on American Hospitals found physicians' satisfaction with electronic medical records (EMRs) is decreasing. Many physicians actually consider this increasingly common technology to be time-consuming and fear that it may compromise patient safety.
In more good news for women suffering from breast cancer a study by the the Swiss drugmaker Novartis has shown that their drug Femara benefits women with hormone-sensitive early breast cancer.
The information encoded in the DNA of an organism is not sufficient to determine the expression pattern of genes. This fact has been known even before the discovery of epigenetics, which refers to external modifications to the DNA that turn genes "on" or "off".
Scientists at Cure Lab, Inc., a biotechnology company based in Canton, Massachusetts, in collaboration with researchers at Boston University and Harvard Medical School have discovered a potential new target for the development of anti-influenza (flu) drugs, including those that may be effective against potentially pandemic influenza strains like H5N1.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Colleen Cleary, ARNP 1500 Associates Dr, Dubuque, IA 52002-2201 Ph: (563) 584-4100 | Ashley Colleen Cleary, ARNP 208 N 12th St, Bellevue, IA 52031-1931 Ph: (563) 872-4008 |
News Archive
The study, published in the journal Science and Technology of Advanced Materials, by Shinichi Arakawa and colleagues at Tokyo Medical and Dental University and Japan's National Institute of Advanced Industrial Science and Technology, evaluated the bactericidal activities of ozone nano-bubble water - also known as NBW3 - against the two main bacterial agents that cause periodontitis as well as its toxicity to human oral tissue cells.
Press Ganey Associates' 2009 Hospital Pulse Report: Physician Perspectives on American Hospitals found physicians' satisfaction with electronic medical records (EMRs) is decreasing. Many physicians actually consider this increasingly common technology to be time-consuming and fear that it may compromise patient safety.
In more good news for women suffering from breast cancer a study by the the Swiss drugmaker Novartis has shown that their drug Femara benefits women with hormone-sensitive early breast cancer.
The information encoded in the DNA of an organism is not sufficient to determine the expression pattern of genes. This fact has been known even before the discovery of epigenetics, which refers to external modifications to the DNA that turn genes "on" or "off".
Scientists at Cure Lab, Inc., a biotechnology company based in Canton, Massachusetts, in collaboration with researchers at Boston University and Harvard Medical School have discovered a potential new target for the development of anti-influenza (flu) drugs, including those that may be effective against potentially pandemic influenza strains like H5N1.
› Verified 8 days ago